Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Chang, Jin Biou ^a,b   Chu, Nain Feng ^c,d   Syu, Jhu Ting ^d   Hsieh, An Tsz ^c   Hung, Yi Ren ^b  

^a YUANPEI UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GERIATRICS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; SEX DIFFERENCE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 82655186580     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-228     Document Type: Article

References (27)

1. Morbidity and mortality in diabetics in the Framingham population, Sixteen year follow-up study. Garcia MJ, McNamara PM, Gordon T, Kannel WB, Diabetes 1974 23 105 111 4359625
2. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Stamler J, Vaccaro O, Neaton JD, Wentworth D, Diabetes Care 1993 16 434 444 10.2337/diacare.16.2.434 8432214 (Pubitemid 23046633)
3. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, Holle R, Diabetologia 1996 39 1540 1545 10.1007/s001250050612 8960840 (Pubitemid 26397365)
4. Why does diabetes increase atherosclerosis? I don't know! Goldberg IJ, J Clin Invest 2004 114 613 615 15343377 (Pubitemid 39578749)
5. The role of AGEs in cardiovascular disease. Jandeleit-Dahm K, Cooper ME, Curr Pharm Des 2008 14 979 986 10.2174/138161208784139684 18473849 (Pubitemid 351753286)
6. Advanced glycosylation end products in tissue and biochemical basis of diabetic complications. Brownlee M, Cerami A, Vlassara H, N Engl J Med 1988 318 1315 1321 10.1056/NEJM198805193182007 3283558
7. Advanced glycosylation in diabetes and aging. Brownlee M, Annu Rev Med 1995 46 223 234 10.1146/annurev.med.46.1.223 7598459
8. Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. Yamagishi S, Matsui T, Ueda S, Nakamura K, Imaizumi T, Cardiovascular Hematological Agents Medicinal Chemistry 2007 5 236 240 (Pubitemid 47180854)
9. Hyperglycemia and cardiovascular disease in type 2 diabetes. Laakso M, Diabetes 1999 48 937 942 10.2337/diabetes.48.5.937 10331395 (Pubitemid 29226337)
10. Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ, Rozek MM, Diabetes Care 1992 15 1156 1167 10.2337/diacare.15.9.1156 1396013
11. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis. Makita Z, Yanagisawwa K, Kuwajima S, Bucala R, Vlassara H, Koike T, Nephrol Dial Transplant 1996 11 31 33 9050032 (Pubitemid 27062908)
12. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H, Proc Natl Acad Sci USA 1994 91 9441 9445 10.1073/pnas.91.20.9441 7937786 (Pubitemid 24297930)
13. Formation of reactive intermediates from Amodori compounds under physiological conditions. Zyzak DV, Richardson JM, Thorpe SR, Baynes JW, Arch Biochem Biophys 1995 316 547 554 10.1006/abbi.1995.1073 7840665
14. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman R, Br Med J 2000 321 405 412 10.1136/bmj.321.7258.405 (Pubitemid 30609442)
15. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF, Diabetes Care 1999 22 1543 1548 10.2337/diacare.22. 9.1543 10480523 (Pubitemid 29418253)
16. Advanced glycation end products in nondiabetic patients with coronary artery disease. Kanauchi M, Tsujimoto N, Hashimoto T, Diabetic Care 2001 24 1620 1623 10.2337/diacare.24.9.1620 (Pubitemid 33716459)
17. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus. Nakamura Y, Horii Y, Nishino T, Shiiki H, Sakaguchi Y, Kagoshima T, Dohi K, Makita Z, Vlassara H, Bucala R, Am J Pathol 1993 143 1649 1656 8256853 (Pubitemid 24058268)
18. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Stitt AW, He C, Friedman S, Scher L, Rossi P, Ong L, Founds H, Li YM, Bucala R, Vlassara H, Mol Med 1997 3 617 627 9323713 (Pubitemid 27465233)
19. High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic Men. A population-based 18-year follow-up study. Kilhovd BK, Juutilainen A, Lehto S, Rönnemaa T, Torjesen PA, Birkeland KI, Berg TJ, Hanssen KF, Laakso M, Arterioscler Thromb Vasc Biol 2005 25 815 820 10.1161/01.ATV.0000158380. 44231.fe 15692098 (Pubitemid 40463875)
20. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Brownlee M, Vlassara H, Cerami A, Diabetes 1985 34 938 941 10.2337/diabetes.34.9.938 4029512 (Pubitemid 15016560)
21. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Sobenin IA, Tertov VV, Koschinsky T, Bunting CE, Slavina ES, Dedov II, Orekhov AN, Atherosclerosis 1993 100 41 54 10.1016/0021-9150(93)90066-4 8318062 (Pubitemid 23166007)
22. Advanced glycation end products stimulate an enhanced neutrophil respiratory burst medicated through the activation of cytosolic phospholipase A2 and generation of arachiondic acid. Wong RK, Pettit AI, Quinn PA, Jennings SC, Davies JE, Ng LL, Circulation 2003 108 1858 1864 10.1161/01.CIR.0000089372. 64585.3B 12963645 (Pubitemid 37296096)
23. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Basta G, Schmidt AM, Caterina R De, Cardiovasc Res 2004 63 582 592 10.1016/j.cardiores.2004.05.001 15306213 (Pubitemid 39078671)
24. The AGE/RAGE axis in diabetes-accelerated atherosclerosis. Jandeleit-Dahm K, Watson A, Soro-Paavonen A, Clin Exp Pharmacol Physiol 2008 35 329 334 10.1111/j.1440-1681.2007.04875.x 18290873 (Pubitemid 351260012)
25. Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention. McNair ED, Wells CR, Qureshi M, Basran R, Pearce C, Orvold J, Devilliers J, Prasad K, Clin Cardiol 2010 33 678 685 10.1002/clc.20815 21089112
26. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and N-(Carboxymethyl)Lysine ELISA. Galler A, Müller G, Schinzel R, Kratzsch J, Kiess W, Münch G, Diabetes Care 2003 26 2609 2615 10.2337/diacare.26.9.2609 12941727 (Pubitemid 37052108)
27. Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? Simm A, Wagner J, Gursinsky T, Nass N, Friedrich I, Schinzel R, Exp Gerontol 2007 42 668 675 10.1016/j.exger.2007.03. 006 17482402 (Pubitemid 46756108)